Detail akcie Balchem online

Business Summary: Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Balchem Corp revenues decreased 2% to $922.4M. Net income increased 3% to $108.5M. Revenues reflect Animal Nutrition & Health segment decrease of 9% to $238.3M, Other and Unallocated segment decrease of 66% to $7.4M, Foreign Countries segment decrease of 10% to $232.8M. Net income reflects Transtn&integration cost-Berrgstrom Acq decrease from $1M (expense) to $10.6M (income).